131 related articles for article (PubMed ID: 16832818)
1. Novel pirfenidone analogues: synthesis of pyridin-2-ones for the treatment of pulmonary fibrosis.
Ammar YA; Ismail MM; El-Sehrawi HM; Noaman E; Bayomi AH; Shawer TZ
Arch Pharm (Weinheim); 2006 Aug; 339(8):429-36. PubMed ID: 16832818
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of novel 1-pyrazolylpyridin-2-ones as potential anti-inflammatory and analgesic agents.
Ismail MM; Ammar YA; El-Zahaby HS; Eisa SI; El-Sayed Barakat S
Arch Pharm (Weinheim); 2007 Sep; 340(9):476-82. PubMed ID: 17647214
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of pirfenidone on acute pulmonary injury and ensuing fibrosis in the hamster model of amiodarone-induced pulmonary toxicity.
Card JW; Racz WJ; Brien JF; Margolin SB; Massey TE
Toxicol Sci; 2003 Sep; 75(1):169-80. PubMed ID: 12832656
[TBL] [Abstract][Full Text] [Related]
4. Local delivery of biodegradable pirfenidone nanoparticles ameliorates bleomycin-induced pulmonary fibrosis in mice.
Trivedi R; Redente EF; Thakur A; Riches DW; Kompella UB
Nanotechnology; 2012 Dec; 23(50):505101. PubMed ID: 23186914
[TBL] [Abstract][Full Text] [Related]
5. Lung fibrosis is ameliorated by pirfenidone fed in diet after the second dose in a three-dose bleomycin-hamster model.
Iyer SN; Margolin SB; Hyde DM; Giri SN
Exp Lung Res; 1998; 24(1):119-32. PubMed ID: 9457473
[TBL] [Abstract][Full Text] [Related]
6. Antifibrotic action of pirfenidone and prednisolone: different effects on pulmonary cytokines and growth factors in bleomycin-induced murine pulmonary fibrosis.
Oku H; Shimizu T; Kawabata T; Nagira M; Hikita I; Ueyama A; Matsushima S; Torii M; Arimura A
Eur J Pharmacol; 2008 Aug; 590(1-3):400-8. PubMed ID: 18598692
[TBL] [Abstract][Full Text] [Related]
7. Epigallocatechin-3-gallate exhibits anti-fibrotic effect by attenuating bleomycin-induced glycoconjugates, lysosomal hydrolases and ultrastructural changes in rat model pulmonary fibrosis.
Sriram N; Kalayarasan S; Sudhandiran G
Chem Biol Interact; 2009 Jul; 180(2):271-80. PubMed ID: 19497426
[TBL] [Abstract][Full Text] [Related]
8. Effects of pirfenidone on procollagen gene expression at the transcriptional level in bleomycin hamster model of lung fibrosis.
Iyer SN; Gurujeyalakshmi G; Giri SN
J Pharmacol Exp Ther; 1999 Apr; 289(1):211-8. PubMed ID: 10087006
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory effect of pirfenidone in the bleomycin-hamster model of lung inflammation.
Iyer SN; Hyde DM; Giri SN
Inflammation; 2000 Oct; 24(5):477-91. PubMed ID: 10921510
[TBL] [Abstract][Full Text] [Related]
10. Effects of lecithinized superoxide dismutase and/or pirfenidone against bleomycin-induced pulmonary fibrosis.
Tanaka KI; Azuma A; Miyazaki Y; Sato K; Mizushima T
Chest; 2012 Oct; 142(4):1011-1019. PubMed ID: 22459774
[TBL] [Abstract][Full Text] [Related]
11. Diallyl sulfide attenuates bleomycin-induced pulmonary fibrosis: critical role of iNOS, NF-kappaB, TNF-alpha and IL-1beta.
Kalayarasan S; Sriram N; Sudhandiran G
Life Sci; 2008 Jun; 82(23-24):1142-53. PubMed ID: 18462759
[TBL] [Abstract][Full Text] [Related]
12. Effect of diet-ingested pirfenidone on pulmonary function, cardiovasculature and blood gas measurements in rats.
Mansoor JK; Chen AT; Schelegle ES; Giri S
Res Commun Mol Pathol Pharmacol; 1999 Mar; 103(3):260-8. PubMed ID: 10509737
[TBL] [Abstract][Full Text] [Related]
13. The novel antifibrotic agent pirfenidone attenuates the profibrotic environment generated by calcineurin inhibitors in the rat salt-depletion model.
Brook NR; Waller JR; Bicknell GR; Nicholson ML
Transplant Proc; 2005; 37(1):130-3. PubMed ID: 15808571
[TBL] [Abstract][Full Text] [Related]
14. Pirfenidone attenuates bleomycin-induced changes in pulmonary functions in hamsters.
Schelegle ES; Mansoor JK; Giri S
Proc Soc Exp Biol Med; 1997 Dec; 216(3):392-7. PubMed ID: 9402144
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of Hu-qi-yin on the bleomycin-induced pulmonary fibrosis in rats.
Zhou XM; Zhang GC; Li JX; Hou J
J Ethnopharmacol; 2007 May; 111(2):255-64. PubMed ID: 17188826
[TBL] [Abstract][Full Text] [Related]
16. Inhibitory effect of emodin on bleomycin-induced pulmonary fibrosis in mice.
Chen XH; Sun RS; Hu JM; Mo ZY; Yang ZF; Jin GY; Guan WD; Zhong NS
Clin Exp Pharmacol Physiol; 2009 Feb; 36(2):146-53. PubMed ID: 18785980
[TBL] [Abstract][Full Text] [Related]
17. Pirfenidone: a novel potential therapeutic agent in the management of chronic allograft rejection.
Dosanjh A
Transplant Proc; 2007 Sep; 39(7):2153-6. PubMed ID: 17889122
[TBL] [Abstract][Full Text] [Related]
18. A kampo medicine, Yin-Chiao-san, prevents bleomycin-induced pulmonary injury in rats.
Yen FL; Wu TH; Liao CW; Lin CC
Phytother Res; 2007 Mar; 21(3):251-8. PubMed ID: 17177325
[TBL] [Abstract][Full Text] [Related]
19. Novel synthesis of [1]-benzothiepino[5,4-b]pyridine-3-carbonitriles and their anti-inflammatory properties.
Girgis AS; Mishriky N; Ellithey M; Hosni HM; Farag H
Bioorg Med Chem; 2007 Mar; 15(6):2403-13. PubMed ID: 17267228
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and biological activity of original pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives as novel dual Nox4/Nox1 inhibitors.
Gaggini F; Laleu B; Orchard M; Fioraso-Cartier L; Cagnon L; Houngninou-Molango S; Gradia A; Duboux G; Merlot C; Heitz F; Szyndralewiez C; Page P
Bioorg Med Chem; 2011 Dec; 19(23):6989-99. PubMed ID: 22041175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
